Xiamen Voke Mold & Plastic Engineering Co., Ltd. (SHE:301196)
China · Delayed Price · Currency is CNY 118.50
+5.65 (5.01%)
Apr 30, 2026, 3:04 PM CST
SHE:301196 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,275 | 2,204 | 1,796 | 1,325 | 939.9 | 1,144 |
Other Revenue | - | - | 22.8 | 16.41 | 18.2 | 15.63 |
| 2,275 | 2,204 | 1,819 | 1,341 | 958.1 | 1,159 | |
Revenue Growth (YoY) | 12.03% | 21.16% | 35.64% | 39.97% | -17.34% | 27.30% |
Cost of Revenue | 1,604 | 1,548 | 1,328 | 940.6 | 663.11 | 788.88 |
Gross Profit | 671.08 | 655.83 | 491.21 | 400.47 | 294.99 | 370.27 |
Selling, General & Admin | 270.43 | 261.25 | 236.74 | 192.93 | 119.71 | 116.11 |
Research & Development | 109.6 | 105.09 | 86.29 | 69.25 | 58.04 | 43.85 |
Other Operating Expenses | -10.6 | -12.06 | 16.82 | 13.55 | 6.21 | 7.32 |
Operating Expenses | 369.43 | 354.28 | 344.03 | 280.76 | 185.57 | 167.25 |
Operating Income | 301.65 | 301.55 | 147.18 | 119.71 | 109.42 | 203.02 |
Interest Expense | - | - | -3.56 | -2.73 | -1.38 | -0.38 |
Interest & Investment Income | 34.53 | 28.21 | 52.11 | 56.74 | 48.17 | 15.98 |
Currency Exchange Gain (Loss) | - | - | 7.7 | 4.29 | 7.11 | -8.71 |
Other Non Operating Income (Expenses) | -13.6 | 0.35 | -1.07 | 1.17 | -0.4 | -0.63 |
EBT Excluding Unusual Items | 322.58 | 330.11 | 202.36 | 179.19 | 162.92 | 209.27 |
Impairment of Goodwill | - | - | -8.32 | - | - | - |
Gain (Loss) on Sale of Investments | 0.24 | 0.24 | -1.21 | 1.68 | 2.06 | -0.91 |
Gain (Loss) on Sale of Assets | -0.68 | -0.63 | -0.13 | 0.68 | 0.09 | 0.31 |
Asset Writedown | -36.29 | -34.71 | -0.46 | -0.84 | -0.97 | -0.28 |
Legal Settlements | - | - | -1.57 | - | - | - |
Other Unusual Items | - | - | 61.73 | 25.88 | 16.45 | 16.96 |
Pretax Income | 285.85 | 295 | 252.4 | 206.6 | 180.54 | 225.35 |
Income Tax Expense | 27.22 | 28.73 | 26.1 | 30.7 | 15.67 | 29.21 |
Earnings From Continuing Operations | 258.63 | 266.27 | 226.3 | 175.9 | 164.87 | 196.14 |
Minority Interest in Earnings | -7.73 | -9.33 | -6.04 | -7.83 | -1.42 | -4.34 |
Net Income | 250.9 | 256.93 | 220.26 | 168.07 | 163.45 | 191.8 |
Net Income to Common | 250.9 | 256.93 | 220.26 | 168.07 | 163.45 | 191.8 |
Net Income Growth | -3.47% | 16.65% | 31.05% | 2.83% | -14.78% | 19.31% |
Shares Outstanding (Basic) | 125 | 125 | 124 | 125 | 125 | 94 |
Shares Outstanding (Diluted) | 125 | 125 | 124 | 125 | 125 | 94 |
Shares Change (YoY) | 0.73% | 0.41% | -0.45% | 0.00% | 33.33% | 0.00% |
EPS (Basic) | 2.01 | 2.06 | 1.77 | 1.35 | 1.31 | 2.05 |
EPS (Diluted) | 2.01 | 2.06 | 1.77 | 1.35 | 1.31 | 2.05 |
EPS Growth | -4.17% | 16.17% | 31.65% | 2.83% | -36.08% | 19.31% |
Free Cash Flow | 85.88 | -1.6 | 103.34 | -105.98 | -49.03 | -6.16 |
Free Cash Flow Per Share | 0.69 | -0.01 | 0.83 | -0.85 | -0.39 | -0.07 |
Dividend Per Share | - | - | 1.100 | 0.900 | 0.700 | 0.600 |
Dividend Growth | - | - | 22.22% | 28.57% | 16.67% | - |
Gross Margin | 29.50% | 29.76% | 27.00% | 29.86% | 30.79% | 31.94% |
Operating Margin | 13.26% | 13.68% | 8.09% | 8.93% | 11.42% | 17.51% |
Profit Margin | 11.03% | 11.66% | 12.11% | 12.53% | 17.06% | 16.55% |
Free Cash Flow Margin | 3.77% | -0.07% | 5.68% | -7.90% | -5.12% | -0.53% |
EBITDA | 435.21 | 430.5 | 257.73 | 206.4 | 168.38 | 256.37 |
EBITDA Margin | 19.13% | 19.53% | 14.17% | 15.39% | 17.57% | 22.12% |
D&A For EBITDA | 133.56 | 128.96 | 110.56 | 86.69 | 58.96 | 53.36 |
EBIT | 301.65 | 301.55 | 147.18 | 119.71 | 109.42 | 203.02 |
EBIT Margin | 13.26% | 13.68% | 8.09% | 8.93% | 11.42% | 17.51% |
Effective Tax Rate | 9.52% | 9.74% | 10.34% | 14.86% | 8.68% | 12.96% |
Revenue as Reported | - | - | 1,819 | 1,341 | 958.1 | 1,159 |
Advertising Expenses | - | - | 3.83 | 3.68 | 3.53 | 2.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.